About: Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates through, Testing Services and Supplements, and Research and Development segments. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; microba microbiome explorer; research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel autoimmune diseases, oncology, and allergy. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: A$0.03 (-2.86%)
MAP ASX Microba Life Sciences Ltd
Microba Life Sciences Ltd share price
Atividade de preço de MAP
Último preço
$ 0,030
Variação (24h)
-0,00 AUD (2,86%)
Volume
18.90K
Volume (média 4 sem.)
-
Abertura
$ 0,04
Variação do dia
$ 0,03 - $ 0,04
Fechamento anterior
$ 0,04
Último negócio
30 Oct, 4:56 am GMT+0
Atrasado
30 Oct, 4:56 am GMT+0
MAP price performance
Atrasado
30 Oct, 4:56 am GMT+0
quote.marketSignals